In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer (Q43736596)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer
scientific article

    Statements

    In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer (English)
    0 references
    Mäkimattila S
    Hietaniemi K
    Kiviluoto T
    Timonen T
    1 September 2001
    1036-1042

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit